Ulrike Wokoun Selected Research

Neoplasms (Cancer)

7/2019	Inhibition of aerobic glycolysis enhances the anti-tumor efficacy of Zoptarelin Doxorubicin in triple-negative breast cancer cells.
4/2017	Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ulrike Wokoun Research Topics

Disease

2	Triple Negative Breast Neoplasms 07/2019 - 04/2017
2	Neoplasms (Cancer) 07/2019 - 04/2017
1	Breast Neoplasms (Breast Cancer) 04/2017

Drug/Important Bio-Agent (IBA)

2	Deoxyglucose (2 Deoxy D glucose)IBA 07/2019 - 04/2017
1	lysine(6)-doxorubicin LHRHIBA 07/2019
1	Adenosine Triphosphate (ATP)IBA 07/2019
1	Metformin (Glucophage)FDA LinkGeneric 04/2017
1	resazurinIBA 04/2017

Therapy/Procedure

1	Therapeutics 04/2017